Data Hint COVID-19 Vax May Improve Immunotherapy Efficacy in Some

Patients with nasopharyngeal cancer who received the Chinese Sinovac COVID-19 vaccine did better on immune checkpoint inhibitor therapy compared with unvaccinated patients, early data suggest.
Medscape Medical News